Non-Current Assets
Available-for-Sale Securities (Non-Current)
Gilead Sciences Available-for-Sale Securities (Non-Current) increased by 4.8% to $2.01B in Q3 2025 compared to the prior quarter. Over 4 years (FY 2020 to FY 2024), Available-for-Sale Securities (Non-Current) shows a downward trend with a -100.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ3 2015
Last reportedQ4 2025
Metric ID:
afs_securities_noncurrentHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $836.00M | $1.10B | $1.31B | $1.43B | $1.34B | $1.28B | $1.25B | $1.33B | $1.33B | $1.16B | $1.16B | $0.00 | $0.00 | $0.00 | $0.00 | $1.91B | $2.01B |
| QoQ Change | — | +31.5% | +19.1% | +9.0% | -6.3% | -4.1% | -2.9% | +6.6% | +0.5% | -13.3% | +0.6% | -100.0% | — | — | — | — | +4.8% |
| YoY Change | — | — | — | — | +59.9% | +16.7% | -4.9% | -7.0% | -0.2% | -9.8% | -6.6% | -100.0% | -100.0% | -100.0% | -100.0% | — | — |
Range$0.00 – $2.01B
CAGR+24.4%
Avg YoY Growth-32.0%
Median YoY Growth-7.0%
Available-for-Sale Securities (Non-Current) at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's available-for-sale securities (non-current)?
- Gilead Sciences (GILD) reported available-for-sale securities (non-current) of $2.01B in Q3 2025.
- What is the long-term trend for Gilead Sciences's available-for-sale securities (non-current)?
- Over 4 years (2020 to 2024), Gilead Sciences's available-for-sale securities (non-current) has grown at a -100.0% compound annual growth rate (CAGR), from $502.00M to $0.00.